• Breaking News

    Sunday, May 10, 2020

    Home Unlabelled Stock Market - Whats preventing the FED from printing more money and creating a larger bubble?

    Stock Market - Whats preventing the FED from printing more money and creating a larger bubble?

    May 10, 2020

    Stock Market - Whats preventing the FED from printing more money and creating a larger bubble?

    Whats preventing the FED from printing more money and creating a larger bubble?

    Posted: 10 May 2020 07:47 AM PDT

    I ask this because all of the investing sub reddits I follow keep saying, "the next down turn is around the corner". Is it though? I would say that what the Fed has already done was pretty irresponsible. Whats to prevent them from continuing to pump up the markets and continue to see ATH? I am not trying to get politial. Just from an investing stand point what is actually going to make the markets go down if everytime bad news is produced, the Fed prints more money? Its like inflation has hit the stock market. How does a bubble actually pop if we just continue to pump it?

    submitted by /u/laminin1
    [link] [comments]

    The Car Is Staging a Comeback, Spurring Oil’s Recovery

    Posted: 10 May 2020 08:47 AM PDT

    https://www.bloomberg.com/news/articles/2020-05-10/the-car-is-staging-a-comeback-spurring-oil-s-recovery

    Gasoline demand is rebounding, suggesting that the car -- at least for now -- is making a comeback. As lockdowns ease and parts of the world reopen for business, driving has emerged as the socially distant transportation mode of choice and is offering some near-term relief to an oil market fresh off its worst crash in history and reeling from an unprecedented collapse in energy demand.

    "People are using more their cars because they are afraid to use public transportation," Patrick Pouyanne, the chief executive of French oil giant Total SA, said.

    submitted by /u/coolcomfort123
    [link] [comments]

    Is this really just a dead cat bounce?

    Posted: 10 May 2020 10:26 AM PDT

    The trading pattern could be (for tech) a V shape recovery like in 2018 but not as for the other sectors. The tech sector really loves free money and low fed funds rates but XLF and XOP don't favor this as well as low oil prices. XRT will really start to dip as turnout becomes underwhelming due to Covid fear the people were fed and lack of disposable income as 33 million have filed for unemployment. The QE ♾ could help finance tech but it would not save the economy if people don't want to spend their money. What do you guys think?

    submitted by /u/MonigMedia
    [link] [comments]

    Fed's effect on the Stock Market

    Posted: 10 May 2020 01:15 PM PDT

    Saw this post earlier today by u/laminin1, and started a reply that got a little lengthy, so I went ahead and made it a separate post.

    So first of all, I am far from an expert on this, but I have been doing a lot of research on the FED and the money supply. As part of a bigger project that I'm working on (that I might present on here some day) I have accumulated some good information on this specific topic. I will present some of this and then share my 2 cents based on what I've learned so far.

    As I started out, one of the first things I wanted to know was how the FEDs balance sheet stacked up in comparison to the major dollar denominated areas of the economy. Here's what I found:

    Cryptos: $.16T

    M0 Money (physical cash): $1.84T

    FED Balance Sheet: $6T (up from about $4T before CV)

    Gold: $7T

    Dollar Denominated Debt (outside of US): $11T

    US 2019 GDP: $21T

    US Housing Market: $30T

    M1 Money (M0+savings/checking deposits): $37T

    US Private and Public Debt: $52T

    Stock Market: $74T

    M2 Money Supply (M0+M1+other liquid assets): $90T

    Derivatives: $1,200T

    Along the way, I learned quite a bit, and have (3) points I'd like to share. Again, these are just my opinions, so hopefully some smarter folks can correct or add to what I've laid out. I'm much more interested in discussing/learning than persuading or being right, so please feel free to pick my points apart.

    1. FED bucks - While $2T of extra dollars in the economy is an astounding number and is certainly unprecedented, I don't think it (directly) affects the stock market as much as I thought before I started reading up about this. For one, while it's impossible to know exactly how much, I think the percentage of FED generated dollars that trickled into the market is rather small (though admittedly, this gets extremely complicated and tough to cover why in a single post). Secondly, even if every single dollar somehow made it into the market, $2T is still only a smaller percentage of the total market cap and would not come close to making up all of the massive retracement we've seen since the March lows. I think that ultimately the optimism the fed purchases create are much more of a factor on the stock market than the actual dollars themselves.

    2. Deflation - If the economy remains in recession for an extended period of time, there is much more outstanding US dollar denominated debt at risk of defaulting than the FED would ever be able to responsibly inject (at least when they still followed the rules of the federal reserve act). The other problem is, even if they do set the printers into overdrive to perfectly match the rate of deflation, the ability to get the right amount of dollars in the right places, is a nearly impossible task. As we've seen with the stimulus packages so far, the government is extremely inept at effectively allocating resources correctly. To fully stop the massive wave of defaults we have coming, we would need a cooperative government, along with the fed, fairly distributing trillions and trillions of dollars with such precision that we got it correct, right down the individual debtor. We have protections in place that restrain the gov and FED from manipulating our economy too much in this manner. This is a good thing, but there really aren't existing processes that would allow for the selective distribution on a massive (yet precise) scale this would require. I could probably do an entire separate post on the money cycle and how money gets into and flows through the economy, but just suffice it to say it is an extremely convoluted, corrupt, and inefficient process. Another problem is, as shown above, nearly $11T of that debt is outside of the US. These economies are mostly all in worse shape than the US and it will be very challenging for them to get their hands on the dollars they need to service their debts as their economies shrink (lookup Milkshake Theory if you are interested in more information on this). The potential for all this massive deleveraging (reduced dollar supply as debors default) and an increase in demand for dollars should drive the dollar up vs other assets (deflation). I think the reason we haven't seen it so far is this will take months and even years to fully play out. Even though savings levels across the board are extremely low (personal, corp, gov, etc), these institutions aren't going to default after just a month or two of a receding economy.

    3. Nowhere else to go with money - So why does the stock market keep going up then? The best conclusion I've been able to reach is, compared to other options the stock market is just as good (or just as bad) as anything else and people still have money on hand that they need to do something with. Yeah, the stock market is in a bubble, but so are many other investment options. I think the big institutions know that deflation is ultimately on the horizon, but as mentioned above, it will take a long time for the deleveraging to play out and while everyone is still flush with cash, there are gains to be made on the bullish short-sightedness. They will be converting to cash as they sell out at these high retracement levels, but again this isn't going to necessarily happen overnight. I think the average retail investor (myself included) expects these moves downward to come more quickly because of how fast and extreme the first move down was. However, if you look back in history, past bear markets played out much slower and longer than that. While the market could tank again next week, it could be also be several months or more.

    So based on this, my strategy for the rest of the year is to hold mostly cash, a little gold and silver (as a safety measure), and I do have some active shorts on (in hinds sight I probably would have gotten into these after some more decidedly downward action, but am fine holding in the meantime). I don't know if this will all play out, but I do not feel comfortable buying in at these prices and am completely fine missing out (on what I believe) to be short term gains of the bull market hysteria I've been seeing.

    Anyway, sorry for the long post, but hopefully someone gets something out of it. Looking forward to reading the replies.

    submitted by /u/Iamthespiderbro
    [link] [comments]

    Unreal market

    Posted: 10 May 2020 05:23 PM PDT

    This market is unreal. I understand the fed and they Their BRR BRR printer is printing away, but for real how much longer can this literally go in a straight line up without another at least small correction. Unemployment is 20% and every day the market goes up 1%. business are starting to open but surely they are not doing anywhere close to what they were doing before the China virus? I feel like at this point people are FOMO buying.

    submitted by /u/Myack_
    [link] [comments]

    Where does everyone get their news?

    Posted: 10 May 2020 11:27 AM PDT

    There's so much noise out there and every "legitimate" news source just uses catchy headlines for more clicks. I often visit CNBC to atleast get a general sense of the current narrative. But are there any "real" financial news sources that merely produce global headlines without bias?

    submitted by /u/saintandy
    [link] [comments]

    What’s moving S&P500 / DOW futures right now?

    Posted: 10 May 2020 06:58 PM PDT

    Sorry for the dumb noob question. When I look at the yahoo finance app it looks like futures are moving, but if I go to my exchange I can't seem to do after hours trading right now.

    I also don't see any stock values moving. What's going on?

    submitted by /u/Que5t10n
    [link] [comments]

    Day Ahead and Sentiments for 11th May 2020

    Posted: 10 May 2020 08:51 PM PDT

    DAY AHEAD

    There can be no hiding from the awful economic data that is now pouring in from all angles as we move well into the second quarter. Australian jobs, UK Q1 GDP, and US retail sales and inflation numbers will be the next key releases to showcase the virus-inflicted damage. But amid growing optimism about the pandemic easing, the Reserve Bank of New Zealand will likely err on the side of caution at its policy meeting, posing a downside risk for the Kiwi and other commodity dollars.

    SENTIMENT

    OVERALL SENTIMENT:

    US stocks continued to grind higher, while Fed Futures edged away from negative interest rates territory to hover around 0%. With interest rates edging higher, Gold lost some momentum and backed off more than 1% from the highs. USD, however, remained weak against most developed currencies except the JPY. With stock sentiment diverging from the economic reality, it has become a market that requires patience as fundamentals will eventually matter again.

    With Australia and New Zealand seemingly doing all the right things to keep the outbreak under control, their currencies are leading the way in this bout of USD weakness. This is likely to continue as food security and optimism on re-opening of economies become key themes going forward.

    submitted by /u/trackrecordasia
    [link] [comments]

    Stock Market Bot

    Posted: 10 May 2020 08:45 PM PDT

    The Twitter handle: Daily Market Updates, @ MarketBot32

    Hi all I made a Twitter bot that you all might be interested in. It's only been running for a few days! The bot, one hour before the market closes tweets out a list of the four biggest movers up as well as the four biggest movers down of the day, as well as a daily Dow Jones update.

    I am open to suggestions on how to improve the bot so if you have any please leave them in the comments thanks!

    submitted by /u/pierce_575
    [link] [comments]

    Datadog and JD.com ahead of earnings??

    Posted: 10 May 2020 04:43 PM PDT

    Bullet question. I was wondering if it's worth jumping on these stocks before their earnings. They are both doing great with an uptrend since months before the CoronaV outbreak.

    Which one would you consider the most?

    submitted by /u/xOnIbAkU
    [link] [comments]

    SpringWorks (SWTX): A Rare Cancer Biotech with Potentially >50% Upside. Recommending BUY.

    Posted: 10 May 2020 08:21 PM PDT

    Last week, we initiated a position in Springworks Therapeutics (NASDAQ: SWTX), and as promised, we're providing our view on the company.

    Summary: Founded in 2017, Springworks is a $1.4B market cap biotech company developing targeted oncology therapies for rare tumor types with high unmet need. We like Springworks for several key reasons:

    • The company has two late-stage (Phase 2/3) programs, nirogacestat and mirdametinib, targeting rare tumor types with high unmet need (either insufficient therapies or no available therapies). Past trial data gives us confidence in their chances of approval, and we expect these candidates to be approved in 2022 and 2023 respectively, upon which they will become first-in-class drugs in their respective indications through their differentiated clinical profiles.
    • Springworks has signed collaborations with major biotech companies to develop several interesting early stage assets in additional oncology indications, providing a degree of validation of Springworks' assets and creating a future growth runway.
    • We anticipate several value-creating milestones over the next year, namely topline data from nirogacestat's registrational Phase 3 trial in mid-2021 and an interim update from mirdametinib's registrational Phase 2b in 1Q21.
    • Our DCF analysis assigns Springworks a price target of $55, assuming an 85% probability of success for nirogacestat and mirdametinib in their main indications, and using an 11% discount rate and 2% terminal growth rate.

    Company Background: Springworks was established in 2017 as a spinoff from Pfizer, which provided the company with initial funding and the development rights to its 4 clinical assets. Springworks raised ~$230M from investors including Bain Capital and OrbiMed Advisors before going public in September 2019.

    1. Late-stage Clinical Programs in Areas of High Unmet Need: Springworks has two late stage programs currently in registrational or potentially registrational trials:

    Nirogacestat. Nirogacestat is an oral, selective gamma secretase inhibitor developed to treat desmoid tumors.

    • Desmoid tumors. Desmoid tumors are highly morbid, soft tissue tumors with an estimated 6,000 patients being treated in the US every year.
    • Unmet need. Though survival rates for desmoid tumors are relatively high compared to other cancer types, desmoid tumors place a heavy burden on patients' quality of life; they can interfere with the function of nearby structures (e.g. intestines), are painful to live with, and highly disfiguring. Treatment has traditionally been via surgical resection, but this method has been associated with recurrence rates of up to 70%. Chemotherapy and other targeted cancer therapies have been used off-label as well, but these have shown inconsistent efficacy and unfavorable safety profiles.
    • Nirogacestat has received FDA breakthrough and orphan drug designation.

    Mirdametinib. Mirdametinib is an oral, selective MEK inhibitor developed to treat NF1-associate plexiform neurofibromas (NF1-PN).

    • NF1-PN. The NF1 gene produces neurofibromin, a protein that represses a key signaling pathway (RAS/MAPK) responsible for the growth of many cancers. When the NF1 gene is mutated, the loss of neurofibromin production allows this pathway to run unchecked, resulting in tumor growth across the body. There are ~100k NF1 patients in the US, and 30-50% of these patients can develop plexiform neurofibromas, which are tumors that grow along nerves.
    • Unmet need. NF1-PN are associated with extreme pain and disfigurement as well as interference with neurocognitive function. First-line therapy is usually surgical resection, but NF1-PN extensive growth patterns along nerves make them hard to completely remove (while risking nerve damage).
    • There is one approved MEK inhibitor for NF1-PN, AstaZeneca's selumetinib, which was approved in April 2020. While the drug works, mirdametinib has demonstrated a potentially superior safety profile vs. selumetinib, which should allow patients to remain on therapy longer and experience more clinical benefit.
    • Mirdametinib has received FDA orphan drug designation.

    2. Promising Clinical Data.

    Nirogacestat. To date, nirogacestat has shown a promising clinical profile in its Phase 1 and 2 trials. The drug is currently enrolling patients in its Phase 3 trial, with progression free survival (PFS, a measure of how long patients live without their tumors growing >20% in size) as the primary endpoint.

    • Phase 1. Nirogacestat achieved an objective response rate (ORR) of 71.4% in its 7-patient Phase 1 trial (5/7), and a 100% disease control rate (DCR). Patients were able to stay on the drug for a median of 49.5 months (at the time of publication, so possibly longer), and none went off treatment due to safety issues.
    • Phase 2. In a heavily pre-treated population (median 4 lines of prior therapy vs. 3 in Phase 1 i.e. sicker patients), nirogacestat again achieved a 100% DCR and a 29.4% ORR. More importantly, 59% of patients remained on drug for more than 2 years. The drug was well tolerated with only 1 patient discontinuing treatment due to side effects.
    • Phase 3. A 115-patient Phase 3 trial is currently enrolling patients. The trial is powered to show a 12-month difference in PFS vs. placebo, and past trials from a similar drug showed that 50% of placebo patients experience disease progression by 8 months, which compares favorably to what nirogacestat has demonstrated in its Phase 1/2 trials.
    • The Phase 3 trial is expected to readout in 2Q/3Q21 and we expect approval of nirogacestat in 2022.

    Mirdametinib.

    • Phase 2. In its Phase 2 trial, Mirdametinib demonstrated a 42% ORR in 8/19 patients. In contrast, selumetinib demonstrated a 74% ORR in its Phase 2 trial. Though selumetinib's Phase 2 data was numerically superior to mirdametinib's, we believe several factors artificially limited mirdametinib's efficacy:
      • Selumetinib's trial enrolled only children while mirdametinib's trial included only patients 16 years or older. Tumors in younger children are considered to be more responsive to therapy than those in adults.
      • Patients in the mirdametinib trial were removed from the trial if they did not show signs of benefit within 12 months, which may have limited the number responses; 30% of selumetinib's patients did not respond until after 12 months on drug.
    • Safety benefits. In its Phase 2, only 5 out of 19 patients (26%) required dose reductions of mirdametinib. In contrast, in selumetinib's Phase 1, 10 out of 24 patients (42%) required dose reductions due to toxicity issues. We believe that this is evidence that mirdametinib is a safer drug than selumetinib, which will be an important differentiating factor for doctors deciding between the two drugs.
    • Phase 2b. Springworks is currently enrolling patients for a 100-patient Phase 2b trial of mirdametinib (primary endpoint ORR) that could support approval in 2023. The trial will enroll an even split of pediatric and adult patients and will not remove patients before 12 months. We expect that mirdametinib will show a similar ORR to selumetinib and differentiate itself via a superior safety profile.

    3. Intriguing Early Stage Programs.

    • Nirogacestat for Multiple Myeloma Therapy. Nirogacestat is also being evaluated as an add-on therapy to BCMA therapies for multiple myeloma, a cancer of the plasma cells with ~27k patients in the US every year. These drugs target a protein called BCMA on the surface of cancer cells, and preclinical data has shown that nirogacestat significantly upregulates the expression of BCMA on cancer cells and enhanced the potency of BCMA-targeting drugs. Springworks has already signed collaborations with Glaxo Smith Kline and Allogene Therapeutics to use nirogacestat in combination trials with their BCMA drugs.
    • BGB-3245. Springworks has also signed a collaboration agreement with Beigene, a leading China biotech company, to develop a novel cancer drug targeting BRAF-mutant solid tumors. BRAF is a validated oncology target that is clinically relevant in melanoma, lung cancer, and colorectal cancer. BGB-3245 has been shown in preclinical models to be effective in inhibiting certain mutant forms of BRAF that currently approved BRAF inhibitors cannot target. A Phase 1 trial for BGB-3245 has been initiated in Australia.

    4. Strong Balance Sheet: As of the end of 2019, Springworks had ~$330M in cash and no debt. This is expected to be sufficient to fund operations and support its 6 clinical trials through the end of 2022. The company has not indicated that its clinical development timelines have been impacted by Covid, but we will be on the lookout for any future guidance.

    5. Experienced Leadership: Springworks is led by a world-class management team with deep pharma industry experience. Selected leadership includes:

    • Chief Executive Officer Saqib Islam is a founding member of the company and was formerly the Chief Business Officer at Moderna. Prior to Moderna, he held senior leadership roles at Alexion Pharmaceuticals (a $20B rare disease biotech).
    • Chief Medical Officer Jens Renstrup was formerly Head of Medical Affairs at Alexion, where he was instrumental in building out its pipeline. Prior to Alexion, he led medical affairs at Glaxo Smith Kline's vaccine division.
    • Head of R&D Stephen Squinto is a venture partner at OrbiMed, a highly respected life science investment firm. He is also a co-founder of Alexion, where he led global operations and R&D for over 20 years.

    6. Risks. Potential investors should be aware that Springworks is exposed to the following key risks as a biotech company:

    • Clinical development risk. Springworks' assets could fail their clinical trials due to unfavorable or uncompetitive clinical data and/or unexpected safety issues.
    • Competitive risk. Springworks' drugs could be leapfrogged by more effective drugs, severely limiting their commercial potential.
    • Financial risk. Unexpected costs/circumstances could lead to the company running out of cash and having to raise dilutive capital and/or shut down.

    Disclosure: We currently own shares of Springworks Therapeutics. This article expresses our own opinions, not Springworks' or any other party's opinion. We are not receiving compensation for this report. We do not have a business relationship with the company mentioned in this report.

    submitted by /u/boccherini-trader
    [link] [comments]

    Which markets or industries do you see perform best in the next decades (geographic vs. industry focus vs. cap size)? How do you build this into a strategy and portfolio to maximize expected risk-adjusted future returns?

    Posted: 10 May 2020 08:15 PM PDT

    I often get confused when people here argue whether one could beat "the market". Which "market" are they referring to? Assuming Equities, which equities and index? MSCI World? S&P500? FTSE100? ASX200? Emerging markets?Many portfolios suggested here seem to suggest a strong U.S. bias for equities, and even an MSCI world would have almost 40% U.S. equity exposure. While it's true that the S&P500 has had strong past returns over many time periods, there's plenty of research suggesting that over the same periods other markets have outperformed.Let's assume for a minute that "the market" is the S&P500 (or MSCI world index, irrelevant for my point). In times of low-cost ETFs widely available and being able to shift the weightings of one's portfolio relatively easily to replicate a strategy, I think it makes sense to compare this reference index and their risk adjusted returns to other indices along different dimensions. For equities, the obvious ones are

    Now obviously past performance does not predict future returns, but it's one data point and can be considered alongside other factors. These include current valuations of such markets or sectors (particularly when it comes to investing lump sums at a certain point of time) and more importantly larger themes such as changes in political landscapes and the geopolitical environment, climate change and shift towards renewables, urbanization (or de-urbanization due to COVID?), digitization, etc.With a lot of data on past performance of different indices available and reflecting on major socioeconomic and political trends that will shape our lives in the next decades, I'd be interested in creating a diversified portfolio using low-cost ETFs, which over the next 20-30 years is likely to outperform the classic bogleheads 3-fund portfolio or an MSCI world and potentially offer higher risk-adjusted returns compared to those indices. Suggestions should be evidence-based on a combination of past returns and outlook into the future, rather than saying "just put your money into FANG or an AI or ROBO-ETF".With that in mind, which mix of markets, or sectors, do you see outperforming over the next decades compared to a S&P500 or MSCI world reference index, how would you build a low-cost portfolio based on that strategy, and with which weightings? Let's discuss!

    submitted by /u/niknikniknikniknik1
    [link] [comments]

    Where to begin?

    Posted: 10 May 2020 04:48 PM PDT

    I consider myself an average joe investor. I know very basic things about the stock market and have worked my way back to even in my portfolio before the crash. I didn't go to school for finance in fact I work in the legal industry. I love finance and especially stocks/investing. I started "learning" how to invest freshman year of college and historically I've profited instead of losing money but I want to start actually learning the market as well as all the different types of investments such as options and I want to learn all the basics so I can be more informed with what I'm doing. Where do I begin? Any help would be greatly appreciated.

    submitted by /u/captshtpst
    [link] [comments]

    Best Security Network Stocks

    Posted: 10 May 2020 09:16 AM PDT

    Hello guys, I was checking some of the major network security companies around(high chance missed some as well) as I believe there is a high growth in the field and I highlighted three of them with quite interesting numbers. CyberArk ($cybr), Qualys ($qlys) and fortinet ($ftnt). Any thoughts on them individually or comparisonwise would be more than welcome :)

    submitted by /u/FrangosV
    [link] [comments]

    My confusion about inflation expectations

    Posted: 10 May 2020 11:13 AM PDT

    With a massive downturn in consumer spending because of the pandemic, deflation on a bunch of goods is likely .. right?

    But there's also a supply side shock essentially doing the opposite in certain areas of the economy.

    Also, "printing" tends to benefit the wealthy and usually increases inequality.. but we have an unusual occurance of cheques going out to regular people that might possibly go on for a little while.

    How does all the above play out inflation wise?? What are your expectations for money going directly to people going forward?

    submitted by /u/youvebeenjammed
    [link] [comments]

    Stock market is almost back to where it was before all this coronavirus crap happened! Makes no FUCKING SENSE! How long can the government keep their Brrrrrrrrr infinite fucking money solution going for!?

    Posted: 10 May 2020 06:31 PM PDT

    Unemployment at record fucking highs, literally the world halting, and yet the god damn market is shooting back up!!! This shit is rigged, all the numbers point don't make sense, the crash is just warming up

    submitted by /u/Misterangry11
    [link] [comments]

    If you are Looking for a Long Term

    Posted: 10 May 2020 10:28 AM PDT

    Hello everyone, I have been looking for cheap good stocks for a long time and also found some branches.

    The following stocks are very interesting and the probability of going out here as the winner is significantly greater than going out as the loser.

    LONG-TERM AND SECURE

    Look at WPX; NWS; AYTU; 3CP; IJ8; AIM; VBI; NNDM; KTOV; GE

    Take a closer look at these companies and look into the future :-)

    submitted by /u/RRAIDD
    [link] [comments]

    What's a good way to estimate option liquidity throughout the day?

    Posted: 09 May 2020 10:53 PM PDT

    I'm writing up an algorithm for some option trading and I'm not sure what the best way to gauge option liquidity is; for instance, if liquidity is low, you might not want to buy too many of that contract, because you won't be able to sell them at the price you want very quickly (or at all!)

    ​

    Is there any metric for measuring/estimating this, or should I just go crazy with trying to make up my own way to estimate option liquidity for my algo?

    submitted by /u/minigunman123
    [link] [comments]

    Cousin wants to use his stimulus check to invest in stocks. What's a good app for a beginner? Ameritrade, Charles Schwab? Any help greatly appreciated

    Posted: 10 May 2020 07:34 AM PDT

    good morning.

    i woke up to a text asking what's a good app for a 19 year old to start/learn about investing in stocks.

    i'm pretty clueless and did some googling and found a few apps that were newbie friendly.

    stumbled here and decided to ask you fine fellas!

    any help /advice is greatly appreciated

    ** edit

    he wants to invest in stocks he likes/thinks might go up later (his words not mine)

    **** edit 2

    thanks guys. appreciate all the info.

    submitted by /u/METHPIPE
    [link] [comments]

    Stock market newbie

    Posted: 10 May 2020 07:04 AM PDT

    I started investing just before the drop. And suffered big time in Lunkin already. Still I went more chips in, with Pharma and Tech stocks, recovered the losses Somehow I don't trust the market as economy situation because of COVID is bad, and sooner than later it will drag the market down. What is my best option? Diversify into some recession proof options or just sell all and sit back? Looking at my 401k already discourages me from investing further.

    submitted by /u/funkyrith
    [link] [comments]

    watchlist size

    Posted: 10 May 2020 07:02 AM PDT

    ive been thinking about this basically since i started, but what do you guys consider a good watch list size. Whats too little or whats overwhelming and too much? i have kept mine anywhere from 10-20 and fine tuned more active ones from there

    submitted by /u/garman1189
    [link] [comments]

    The Unemployment Claims

    Posted: 09 May 2020 08:35 PM PDT

    The unemployment claims for the last 7 weeks, around 33 million, is higher than the summation of the past 7 recessions.

    Recession Unemployment Claims in millions 7 weeks period
    Coronavirus 33.217 Mar-Apr 2020
    The Great Recession 4.597 Feb-Mar 2009
    Dot-com 3.333 Sep-Oct 2001
    Gulf War 3.466 Feb-Mar 1991
    Energy Crisis 4.645 Sep-Oct 1982
    1980 Recession 4.252 Apr-Jun 1980
    Oil Embargo 3.814 Feb-Mar 1975
    Tech Crash 2.242 Oct-Nov 1970
    submitted by /u/diyinvestment
    [link] [comments]

    Studying about stock market for the past 9 months, thinking of attending to a college

    Posted: 09 May 2020 08:05 PM PDT

    Hello, i'm 21 years old and I've been studying about stock market for the past 9 months. I've learned a lot about the stock market but i'm pretty sure I still have to read many books.

    I've managed to increase my portfolio to 45% pre-corona and right now I'm at 17%

    anyway i'll get straight to the point now. I've done a lot of jobs but all of these were not related to the stock market. I would like to get a job which will help me get more knowledge on the stock market.

    Would you recommend me to spend 3-4 years on a bachelor degree just to be able to find a job in a company related to stock market?

    if yes, What would that job be? also what college degree would be the best choice?

    submitted by /u/bxam
    [link] [comments]
    Read more
    at

    No comments:

    Post a Comment